Indo Us Biotech share news, announcements and annual reports
NSE: INDOUSBSE: 541304Agricultural Food & other ProductsSmall Cap
Indo Us Biotech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2018 on BSE, Sep 2024 on NSE
Last close ₹73.54down ₹4.82 (6.15%)BSE ₹73.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹78.36.
30 Oct: open ₹79.79, high ₹83.48, low ₹72.00
52-week range of traded prices to 30 Oct 2026
₹57.50Low, 26 Oct 2026₹159.00High, 27 Nov 2025
- Under NSE's short-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹147 Cr2,332nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.60
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.48
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 47,85632.2% delivered
Indo Us Biotech routine notices
35 filed, newest first.
Oct 2026
Sep 2026
6 Sep · Routine
Aug 2026
Jul 2026
21 Jul · Routine
5 Jul · Routine
Jun 2026
May 2026
Apr 2026
Mar 2026
Jan 2026
Dec 2025
Nov 2025
15 Nov · Routine
Oct 2025
Sep 2025
Aug 2025
29 Aug · Routine
Jul 2025
Jun 2025
May 2025
27 May · Routine
Apr 2025
Mar 2025
Feb 2025
12 Feb · Routine
Jan 2025
Dec 2024
Nov 2024
23 Nov · Routine
15 Nov · Routine
15 Nov · Routine
Oct 2024
Sep 2024